# Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders

> **NCT03198234** · PHASE1 · TERMINATED · sponsor: **Roncarolo, Maria Grazia, MD** · enrollment: 5 (actual)

## Conditions studied

- AML - Acute Myeloid Leukemia
- MDS (Myelodysplastic Syndrome)
- Mixed Phenotype Acute Leukemia
- NHL - Non-Hodgkin's Lymphoma
- Hodgkin's Lymphoma
- ALL

## Interventions

- **BIOLOGICAL:** T-allo10

## Key facts

- **NCT ID:** NCT03198234
- **Lead sponsor:** Roncarolo, Maria Grazia, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-30
- **Primary completion:** 2021-11-11
- **Final completion:** 2021-11-11
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Lack of Enrollment
- **Last updated:** 2024-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198234, "Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03198234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*